➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Moodys
Baxter
Dow
Merck
Medtronic

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Patent: 6,165,713

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,165,713
Title: Composition and methods relating to DNA mismatch repair genes
Abstract:Genomic sequences of human mismatch repair genes are described, as are methods of detecting mutations and/or polymorphisms in those genes. Also described are methods of diagnosing cancer susceptibility in a subject, and methods of identifying and classifying mismatch-repair-defective tumors. In particular, sequences and methods relating to human mutL homologs, hMLH1 and hPMS1 genes are provided.
Inventor(s): Liskay; Robert M. (Lake Oswego, OR), Bronner; C. Eric (Portland, OR), Baker; Sean M. (Portland, OR), Bollag; Roni J. (Martinez, GA), Kolodner; Richard D. (Jamaica Plain, MA)
Assignee: Oregon Health Sciences University (Portland, OR) Dana-Farber Cancer Institute (Boston, MA)
Application Number:08/961,810
Patent Claims:see list of patent claims

Details for Patent 6,165,713

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04   Start Trial Oregon Health Sciences University (Portland, OR) Dana-Farber Cancer Institute (Boston, MA) 2013-12-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04   Start Trial Oregon Health Sciences University (Portland, OR) Dana-Farber Cancer Institute (Boston, MA) 2013-12-17 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04   Start Trial Oregon Health Sciences University (Portland, OR) Dana-Farber Cancer Institute (Boston, MA) 2013-12-17 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Johnson and Johnson
Mallinckrodt
Moodys
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.